Articolo L’Altra Medicina N. 94 – 04/2020

  1. Castelli WP, Anderson K, Wilson PW, Levy D. Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol. 1992; (1-2): 23-8
  2. Mach et coll. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European Heart Journal. 2020; 41(1): 111–188
  3. Kang JH, Nguyen QN, Mutka, Le QA. Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment. J Pharm Pract. 2017 Oct;30(5):521-527. doi: 10.1177/0897190016674407. Epub 2016 Oct 24
  4. Maruthur NM, Wang NY, and Appel LJ. Lifestyle Interventions Reduce Coronary Heart Disease Risk. Results From the PREMIER Trial. Circulation. 2009; 119(15): 2026–2031.